The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions

The validated EndoPredict assay is a novel tool to predict the risk of metastases of patients with estrogen receptor positive, HER2 negative breast cancer treated with endocrine therapy alone. It has been designed to integrate genomic and clinical information and includes clinico-pathological factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Berit Maria, Keil, Elke, Lehmann, Annika, Winzer, Klaus-Jürgen, Richter-Ehrenstein, Christiane, Prinzler, Judith, Bangemann, Nikola, Reles, Angela, Stadie, Sylvia, Schoenegg, Winfried, Eucker, Jan, Schmidt, Marcus, Lippek, Frank, Jöhrens, Korinna, Pahl, Stefan, Sinn, Bruno Valentin, Budczies, Jan, Dietel, Manfred, Denkert, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694878/
https://www.ncbi.nlm.nih.gov/pubmed/23826382
http://dx.doi.org/10.1371/journal.pone.0068252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694878/
https://www.ncbi.nlm.nih.gov/pubmed/23826382
http://dx.doi.org/10.1371/journal.pone.0068252

Ejemplares similares